Practitioner Advocacy

 

Practitioners are not prohibited from advocating on behalf of the member and are advised of the following:

The following information was distributed to our entire medical group (IPA) or MSO contacts on March 24, 2008 via electronic mail. The attached Pneumonia Vaccine Letter regarding administration of the Pneumovax vaccine including billing procedures along with the postcard that was mailed to our members is included below for your review. Please help us to ensure that our AHP members obtain their needed immunization. If you have any questions you may email our Provider Services Department or you may call our office during normal business hours.

  • The expectation to educate members regarding health needs.
  • To share findings of medical history and physical exams.
  • To discuss potential treatment options (including those that may be self-administered) and the risks, benefits and consequences of treatment or non-treatment.
  • The side effects and management of symptoms (without regard to plan coverage), and
  • Recognize that the member has the right to receive sufficient information, to be able to provide input into the proposed treatment plan and has the final say in the course of action to take among clinically acceptable choices.